Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00106743 · ClinicalTrials.gov registry record

Natural History and Genetic Studies of Usher Syndrome

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
249
Enrollment target

NCT00106743: Completed study, sponsored by National Eye Institute (NEI).

NCT00106743 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 249 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00106743 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
249 participants
Enrollment target

Study Summary

This study will explore clinical and genetic aspects of Usher syndrome, an inherited disease causing deafness or impaired hearing, visual problems, and, in some cases, unsteadiness or balance problems. Patients with type 1 Usher syndrome usually are deaf from birth and have speech and balance problems. Patients with type 2 disease generally are hearing impaired but have no balance problems. Patients with type 3 disease have progressive hearing loss and balance problems. All patients develop retinitis pigmentosa, an eye disease that causes poor night vision and eventually, blindness. Patients of any age with Usher syndrome may be eligible for this study. Patients who have had eye and hearing evaluations are asked to send their medical records to the research team at the National Eye Institute (NEI) for review. They are also asked to have a blood sample drawn by a medical professional and sent to NEI for genetic analysis. Finally, they are interviewed about their family histories, particularly about other relative with eye disease. Patients who have not been evaluated previously have the following tests and procedures at NIH: * Family medical history, especially regarding eye disease. A family tree is drawn. * Blood draw for genetic studies of Usher syndrome. * Eye examination to assess visual acuity and eye pressure, and to examine pupils, lens, retina, and eye movements. * Electroretinogram (ERG) to test the function of visual cells. Wearing eye patches, the patient sits in a dark room for 30 minutes. Electrodes are taped to the forehead and the eye patches are removed. The surface of the eye is numbed with eye drops and contact lenses are placed on the eyes. The patient looks inside a hollow, dark globe and sees a series of light flashes. Then a light is turned on inside the globe and more flashes appear. The contact lenses sense small electrical signals generated by the retina when the light flashes. * Fluorescein angiography to evaluate the eye's blood vessels.

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2005-03-21
Est. Completion 2019-04-30
National Eye Institute (NEI)

221 total trials

What the finished NCT00106743 record still lists

NCT00106743 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00106743 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00106743 about?

NCT00106743 is a clinical study titled "Natural History and Genetic Studies of Usher Syndrome". This study will explore clinical and genetic aspects of Usher syndrome, an inherited disease causing deafness or impaired hearing, visual problems, and, in some cases, unsteadiness or balance problems. Patients with type 1 Usher syndrome usually are deaf from birth and have speech and balance proble...

What is the current status of trial NCT00106743?

This trial is currently completed. The enrollment target is 249 participants. The study started on 2005-03-21. Estimated completion is 2019-04-30.

Who is sponsoring clinical trial NCT00106743?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04628767 · 249 participants · Phase 2

    Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • NCT05834907 · 249 participants · NA

    Hands and Hearts Together

  • NCT06067555 · 249 participants · Early Phase 1

    Intradermal Influenza Vaccination

  • NCT06588478 · 249 participants · Phase 2

    A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00106743, the US trial registry maintained by the National Library of Medicine. NCT00106743 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.